| Authors: |
Morand EF; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia. Electronic address: eric.morand@monash.edu., Dall'Era M; Division of Rheumatology, University of California San Francisco School of Medicine, San Francisco, CA, USA., Sanchez-Guerrero J; Division of Rheumatology, Mount Sinai Hospital and Toronto Western Hospital, University of Toronto, Toronto, ON, Canada., Pearson DR; Department of Dermatology, University of Minnesota, Minneapolis, MN, USA., Werth VP; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Corporal Michael J Crescenz VAMC, Philadelphia, PA, USA., Wenzel J; Department of Dermatology and Allergy, Cluster of Excellence ImmunoSensation(3), University Hospital of Bonn, Bonn, Germany., Roy S; Ares Trading, Eysins, Switzerland, an affiliate of Merck., Kleinmond C; Merck Healthcare, Darmstadt, Germany., Gühring H; Merck Healthcare, Darmstadt, Germany., Sgouroudi E; Merck Healthcare, Darmstadt, Germany., Klopp-Schulze L; Merck Healthcare, Darmstadt, Germany., Moreau F; EMD Serono Research and Development Institute, Billerica, MA, USA, an affiliate of Merck., Fernandez-Ruiz R; EMD Serono Research and Development Institute, Billerica, MA, USA, an affiliate of Merck., Furie R; Northwell, New Hyde Park, NY; Division of Rheumatology, Northwell, Great Neck, NY, USA. |
